LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) (IMUC), a biotechnology company, announced today that Navdeep Jaikaria, Ph.D., former managing director of equity research and senior biotechnology analyst at Rodman & Renshaw, has been elected to the company’s board of directors.
